Online first
Review article
Published online: 2025-03-11

open access

Page views 112
Article views/downloads 20
Get Citation

Connect on Social Media

Connect on Social Media

Pre-hospital management of patients with implantable cardioverter-defibrillators shocks — procedure proposal

Wojciech Telec1, Tomasz Kłosiewicz2, Ada Dylik2, Adam Wawrzyniak2, Natalia Urbanowicz2, Roland Podlewski2

Abstract

The number of implantable cardioverter-defibrillators (ICD) has broadened over the years, with indications including conditions like ischaemic and non-ischaemic cardiomyopathies, heart failure, and certain ventricular arrhythmias. Consequently, the number of people with ICDs has risen significantly, necessitating that healthcare professionals and emergency medical services be proficient in handling the distinctive challenges associated with the high-energy shocks delivered by these devices. The article highlights the importance of a structured approach to managing ICD shocks in pre-hospital settings to improve patient outcomes and ensure timely, appropriate care. The article also describes types of cardioverters—defibrillators and the differences between adequate and inappropriate discharges. The article also described the rules in the case of adequate and inappropriate discharges. The management algorithm proposed by the authors may be useful in the care of any patient with an ICD discharge. The authors also recommend that a magnet for deactivating high-energy discharges should be obligatory equipment in every ambulance. In the end, the rules of conduct in the case of patients with an implanted ICD who experience sudden cardiac arrest are described.

Article available in PDF format

View PDF Download PDF file

References

  1. Zeppenfeld K, Tfelt-Hansen J, de Riva M, et al. ESC Scientific Document Group. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022; 43(40): 3997–4126.
  2. Haugaa KH, Tilz R, Boveda S, et al. Implantable cardioverter defibrillator use for primary prevention in ischaemic and non-ischaemic heart disease-indications in the post-DANISH trial era: results of the European Heart Rhythm Association survey. Europace. 2017; 19(4): 660–664.
  3. Zabel M, Willems R, Lubinski A, et al. EU-CERT-ICD Study Investigators. Clinical effectiveness of primary prevention implantable cardioverter-defibrillators: results of the EU-CERT-ICD controlled multicentre cohort study. Eur Heart J. 2020; 41(36): 3437–3447.
  4. Gold MR, Lambiase PD, El-Chami MF, et al. UNTOUCHED Investigators*. Primary results from the understanding outcomes with the S-ICD in primary prevention patients with low ejection fraction (UNTOUCHED) trial. Circulation. 2021; 143(1): 7–17.
  5. Yafasova A, Butt JH, Elming MB, et al. Long-term follow-up of DANISH (the danish study to assess the efficacy of icds in patients with nonischemic systolic heart failure on mortality). Circulation. 2022; 145(6): 427–436.
  6. Januszkiewicz Ł, Grabowski M, Farkowski MM, et al. Implantable cardioverter-defibrillators in Poland compared with other European countries from the patient's perspective: insights from the EHRA patient survey. Int J Environ Res Public Health. 2023; 20(6).
  7. Li J, Zhang Y, Long M, et al. Out-of-hospital cardiac arrest patients with implantable cardioverter-defibrillators: What are their outcomes? Resuscitation. 2020; 157: 141–148.
  8. Rudic B, Tülümen E, Fastenrath F, et al. Incidence, mechanisms, and clinical impact of inappropriate shocks in patients with a subcutaneous defibrillator. Europace. 2020; 22(5): 761–768.
  9. Matlock DD, Peterson PN, Heidenreich PA, et al. Regional variation in the use of implantable cardioverter-defibrillators for primary prevention: results from the National Cardiovascular Data Registry. Circ Cardiovasc Qual Outcomes. 2011; 4(1): 114–121.
  10. Biel B, Skoczyński P, Hrymniak B, et al. Outcomes for patients with implanted cardioverter-defibrillators admitted to the Emergency Department due to electrical shock during the pre-pandemic and COVID-19 era. Kardiol Pol. 2024; 82(2): 156–165.
  11. Torres F, Camacho C, Suarez R, et al. Patient management of emergencies medical services in patients with implantable cardioverter desfibrillator. What about professionals should know? Resuscitation. 2014; 85: S112.
  12. Ghzally Y, Mahajan K. Implantable Defibrillator, Available from:. https://www.ncbi.nlm.nih.gov/books/NBK459196/.
  13. Soundarraj D, Thakur RK, Gardiner JC, et al. Inappropriate ICD therapy: does device configuration make a difference. Pacing Clin Electrophysiol. 2006; 29(8): 810–815.
  14. Soar J, Böttiger BW, Carli P, et al. European Resuscitation Council Guidelines 2021: Adult advanced life support. Resuscitation. 2021; 161(4): 115–151.
  15. Watanabe E, Okajima K, Shimane A, et al. Inappropriate implantable cardioverter defibrillator shocks-incidence, effect, and implications for driver licensing. J Interv Card Electrophysiol. 2017; 49(3): 271–280.
  16. Hakamata T, Otsuki S, Izumi D, et al. Clinical impact of ECG changes on oversensing of subcutaneous implantable cardioverter-defibrillators. Heart Rhythm. 2022; 19(10): 1704–1711.
  17. Mitkowski P. Podstawy terapii przy użyciu wszczepialnych kardiowerterów-defibrylatorów: dyskryminatory arytmii. Kardiologia po Dyplomie. 2011; 10(5): 81–84.
  18. Poole JE, Johnson GW, Hellkamp AS, et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 2008; 359(10): 1009–1017.
  19. Beets MT, Forringer E. Urgent implantable cardioverter defibrillator deactivation by unconventional means. J Pain Symptom Manage. 2011; 42(6): 941–945.
  20. Maurizio S. Guidance of clinical magnet application of inhibition of inappropriate shock in patient of subcutaneous implantable cardioverter defibrillators: a review of the literature. Online Journal of Cardiology Research & Reports. 2021; 5(1).
  21. Betz JK, Katz DF, Peterson PN, et al. Outcomes among older patients receiving implantable cardioverter-defibrillators for secondary prevention: from the NCDR ICD registry. J Am Coll Cardiol. 2017; 69(3): 265–274.
  22. Ladejobi A, Pasupula DK, Adhikari S, et al. Implantable defibrillator therapy in cardiac arrest survivors with a reversible cause. Circ Arrhythm Electrophysiol. 2018; 11(3): e005940.